Reversed-polarity Treg cell TCRs provide a shock
Crossref DOI link: https://doi.org/10.1038/ni.3289
Published Online: 2015-10-20
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peakman, Mark
Sewell, Andrew K
Text and Data Mining valid from 2015-10-20
Article History
First Online: 20 October 2015
Competing interests
: M.P. and King's College London have a license agreement with UCB Pharma to develop a peptide-based immunotherapy for type 1 diabetes.